Evidence map›Paper›PMID 41835098›Full record

ReviewFrontiers in rehabilitation sciences2026

Transcranial stimulation as a possible therapeutic proposal in long COVID.

Lidiane Palheta Miranda Dos Santos, Julliana Vieira Leão, Ketelen Yasmim Braga de Moraes Silva, Danilo Lameira Dos Santos, Chrisllane Nascimento Batista, Jonna Almeida Barros, Alna Carolina Mendes Paranhos, Ápio Ricardo Nazareth Dias, Luiz Fábio Magno Falcão

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in rehabilitation sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lidiane Palheta Miranda Dos SantosCentro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.
Julliana Vieira LeãoPrograma de Pós Graduação em Biologia Parasitária na Amazônia, Universidade do Estado do Pará, Belém, Brazil.
Ketelen Yasmim Braga de Moraes SilvaCentro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.
Danilo Lameira Dos SantosCentro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.
Chrisllane Nascimento BatistaCentro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.
Jonna Almeida BarrosCentro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.
Alna Carolina Mendes ParanhosCentro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.
Ápio Ricardo Nazareth DiasCentro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.
Luiz Fábio Magno FalcãoCentro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic triggered an unprecedented global health crisis, with significant repercussions on the mental and neurological health of millions of individuals. Long COVID, characterized by persistent and debilitating symptoms, including chronic fatigue, pain, cognitive impairment, and mood swings, represents a substantial therapeutic challenge. In this context, neuromodulation emerges as a promising therapeutic strategy, offering new perspectives for the management of refractory neurological symptoms. This article aims to critically review the current evidence on the use of neuromodulation in patients with long COVID.

Indexed as

long COVIDneurological rehabilitationneuromodulationtherapeutic interventionstranscranial stimulation

Identifiers

PMID41835098
PMCPMC12982166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.